Can a Basic Amino Acid Help Protect the Aging Brain?
Key Takeaways:
- Arginine may help keep problematic proteins in check. In cell and animal models, the amino acid arginine reduced the aggregation of a particularly sticky protein fragment and lowered plaque-like buildup in brain tissue.
- Its actions go beyond protein cleanup. Arginine also appeared to dial down inflammatory signaling in the brain and was linked to better performance on behavioral tests in animals.
- An everyday molecule with repurposing potential. Because arginine is inexpensive and already used clinically in other contexts, it is being explored as a candidate for repositioning—but research is still preclinical, and supplement doses in this study do not translate directly to humans.
Researchers in Japan recently took a closer look at arginine, a naturally occurring amino acid that the body already uses in multiple metabolic pathways. In lab experiments, they found that arginine acts as a kind of “chemical chaperone,” helping vulnerable proteins maintain their proper shape and blocking the formation of highly aggregation-prone fragments at higher concentrations. In two different animal models engineered to overproduce these fragments, oral arginine reduced overall protein accumulation and lessened downstream toxicity, suggesting that it can influence both how much problematic protein forms and how it behaves once it is present.
How Arginine Acts on Protein Buildup
In a mouse model, the benefits extended from biochemistry to brain tissue and behavior. Animals given arginine had fewer plaque-like deposits and lower levels of insoluble protein in the brain, and they performed better on tasks used to probe learning and memory. At the molecular level, arginine also reduced the expression of genes linked to pro‑inflammatory cytokines, hinting that it may calm neuroinflammatory processes that typically accompany protein buildup. This dual effect—less aggregation and a quieter inflammatory response—has led the authors to propose arginine as a candidate for broader use in protein-misfolding conditions, while emphasizing that their work is still early-stage and in animals.
What This Could Mean for Longevity
From a longevity perspective, the study is less a green light to megadose arginine and more an example of how simple, well-known molecules might be repurposed to nudge fundamental brain processes. Because arginine is already used clinically and can reach the brain, it could move into human trials faster than a brand-new compound, but key questions remain about optimal dosing, long‑term safety, and whether the same effects will hold in people.
Arginine is already present in many everyday foods. Rich sources include nuts (like peanuts, almonds, walnuts, and Brazil nuts), seeds (especially pumpkin, sesame, sunflower, and watermelon seeds), poultry and other meats, dairy products, eggs, soy foods, chickpeas, lentils, and whole grains such as oats and brown rice.
For now, the takeaway is that protein quality control and neuroinflammation are modifiable levers—and that some of the tools to influence them may come from familiar nutrients.
References:
- Kanako Fujii, Toshihide Takeuchi, Yuzo Fujino, Noriko Tanaka, Nao Fujino, Akiko Takeda, Eiko N. Minakawa, Yoshitaka Nagai. Oral administration of arginine suppresses Aβ pathology in animal models of Alzheimer\'s disease. Neurochemistry International, 2025; 191: 106082 DOI: 10.1016/j.neuint.2025.106082